Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|December 15, 2004
Norwood expands into parts of Europe
Melbourne, Australia-Norwood EyeCare, the ophthalmic devices subsidiary of Norwood Abbey Ltd., is expanding its territory to include Italy, Belgium, the Netherlands, and Luxembourg. The company has appointed distributors in those countries for its Centurion SES System with EpiEdge.
Advertisement
Melbourne, Australia-Norwood EyeCare, the ophthalmic devices subsidiary of Norwood Abbey Ltd., is expanding its territory to include Italy, Belgium, the Netherlands, and Luxembourg. The company has appointed distributors in those countries for its Centurion SES System with EpiEdge.
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Ophthalmic care uncommon after tamoxifen initiation
2
Empire Forum 2026: Ambati on K8 phase 2 results in geographic atrophy
3
Global Summit for Eye Health 2026: Turning pledges into eye care
4
Eyedaptic launches Eva, an agentic AI visual assistant for patients with retinal disease
5